You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 15.9 KDa. Observed: 17-35 KDa, reducing conditions
Human
Ser21-Gly152
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.5 KDa. Observed: 17 KDa, reducing conditions
Human
Glu27-Asp175
C-6His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 9.74 KDa. Observed: 10-15 KDa, reducing conditions
Human
Gln24-Gln100
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 63.5 KDa. Observed: 61 KDa, reducing conditions
Human
Glu19-Glu569
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.6 KDa. Observed: 30 KDa, reducing conditions
Human
Gln30-Trp248
C-6His
10 μg, 50 μg, 500 μg, 1 mgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 88.4 KDa. Observed: 95-140 KDa, reducing conditions
Human
Ala22-Arg788
C-Avi-6His
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.3 KDa. Observed: 60-90 KDa, reducing conditions
Human
Ala22-Glu381
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.5 KDa. Observed: 68 KDa, reducing conditions
Human
Gln35-Pro419
C-6His
10 μg, 50 μg, 1 mg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 35 KDa. Observed: 48 KDa, reducing conditions
Human
Gln35-Ile335
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.6 KDa. Observed: 50-60 KDa, reducing conditions
Human
Val32-Lys487
C-6His
10 μg, 50 μg, 500 μg, 1 mg